Canada-USA (CANUSA)Peritoneal Dialysis Study Group Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes.J Am Soc Nephrol1996; 7: 198–207.
2.
FungL., PollockC.A., CatersonR.J.. Dialysis adequacy and nutrition determine prognosis in continuous ambulatory peritoneal dialysis patients.J Am Soc Nephrol19967: 737–44.
3.
AvramM.M., FeinP.A., BonominiL.. Predictors of survival in continuous ambulatory peritoneal dialysis patients: a five-year prospective study.Perit Dial Int1996; 16(Suppl 1): S190–4.
4.
SpiegelD.M., BreyerJ.A.. Serum albumin: a predictor of long-term outcome in peritoneal dialysis patients.Am J Kidney Dis1994; 23: 283–5.
5.
MaiorcaR., BrunoriG., ZubaniR.. Predictive value of dialysis adequacy and nutritional indices for mortality and morbidity in CAPD and HD patients. A longitudinal study.Nephrol Dial Transplant1995; 10: 2295–205.
6.
Diaz-BuxoJ.A., LowneE.G., LewN.L., ZhangS.M., ZhuX., LazarusJ.M.. Associates of mortality among peritoneal dialysis patients with special reference to peritoneal transport rates and solute clearance.Am J Kidney Dis1999; 33: 523–34.
7.
KaysenG.A.. Hypoalbuminemia in dialysis patients.Semin Dial1996; 9: 249–56.
8.
YeunJ.Y., KaysenG.A.. Factors influencing serum albumin in dialysis patients.Am J Kidney Dis1998; 32(suppl): S118–25.
9.
KaysenG.A., SchoenfeldP.Y.. Albumin homeostasis in patients undergoing continuous ambulatory peritoneal dialysis.Kidney Int1984; 25: 107–14.
10.
KaganA., Bar-KhayimY.. Role of peritoneal loss of albumin in the hypoalbuminemia of continuous ambulatory peritoneal dialysis patients: relationship to peritoneal transport of solutes.Nephron1995; 71: 314–20.
11.
HanD.S., LeeS.W., KangS.W.. Factors affecting low values of serum albumin in CAPD patients.Adv Perit Dial1996; 12: 288–92.
12.
HartyJ.C., BoultonH., VenningM.C., GokalR.. Is peritoneal permeability an adverse risk factor for malnutrition in CAPD patients?Miner Electrolyte Metab1996; 22: 97–101.
13.
YeunJ.Y., KaysenG.A.. Acute phase proteins and peritoneal dialysate albumin loss are the main determinants of serum albumin in peritoneal dialysis patients.Am J Kidney Dis1997; 30: 923–7.
14.
HeafJ.G., HonoreK., ValeurD., RandlovA.. The effect of oral protein supplements on the nutritional status of malnourished CAPD patients.Perit Dial Int1999; 19: 78–81.
15.
JonesC.U., NewsteadC.G., WillE.J., SmyeS.W., DavisonA.M.. Assessment of nutritional status in CAPD patients: serum albumin is not a useful measure.Nephrol Dial Transplant1997; 12: 1406–13.
16.
UribarriJ., DimaanoF., LondonR.D., DowlingJ., MarcusR.G.. lncrease in Kt/V increased serum albumin but not nPCR in a group of patients on continuous peritoneal dialysis.Perit Dial Int1997; 17: 511–3.
17.
StruijkD.G., KredietR.T., KoomenG.C., BoeschotenE.W., AriszL.. The effect of serum albumin at the start of continuous ambulatory peritoneal dialysis treatment on patient survival.Perit Dial Int1994; 14: 121–6.
18.
KangD.H., YoonK.I., ChoiK.B.. Relationship of peritoneal membrane transport characteristics to the nutritional status in CAPD patients.Nephrol Dial Transplant1999; 14: 1715–22.
19.
Cueto-ManzanoA.M., EspinosaA., HernandezA., Correa-RotterR.. Peritoneal transport kinetics correlate with serum albumin but not with the overall nutritional status in CAPD patients.Am J Kidney Dis1997; 30: 229–36.
20.
NolphK.D., MooreU.L., ProwantB.. Cross sectional assessment of weekly urea and creatinine clearances and indices of nutrition in continuous ambulatory peritoneal dialysis patients.Perit Dial Int1993; 13: 178–83.
21.
WangT., HeimburgerO., WaniewskiJ., BergstromJ., LindholmB.. Increased peritoneal permeability is associated with decreased fluid and small-solute removal and higher mortality in CAPD patients.Nephrol Dial Transplant1998; 13: 1242–9.
22.
ChurchillD.N., ThorpeK.E., NolphK.D., KeshaviahP.R., OreopoulosD.G., PageD.. Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. The Canada-USA (CANUSA) Peritoneal Dialysis Study Group.J Am Soc Nephrol1998; 9: 1285–92.
23.
MalhotraD., TzamaloukasA.H., MurataGil, FoxL., GoldmanR.S., AvasthiP.S.. Serum albumin in continuous peritoneal dialysis: its predictors and relationship to urea clearance.Kidney Int1996; 50: 243–9.
24.
DaviesS.J., PhillipsL., RussellG.I.. Peritoneal solute transport predicts survival on CAPD independently of residual renal function.Nephrol Dial Transplant1998; 13: 962–8.
25.
WangT., WaniewskiJ., HeimburgerO., WerynskiA., LindholmB.. A quantitative analysis of sodium transport and removal during peritoneal dialysis.Kidney Int1997; 52: 1609–16.
26.
JonesC.H., SmyeS.W., NewsteadC.G., WillE.J., DavisonA.M.. Extracellular fluid volume determined by bioclectric impedance and serum albumin in CAPD patients.Nephrol Dial Transplant1998; 13: 393–7.
KoppleJ.D., BernardD., MessanaJ.. Treatment of malnourished CAPD patients with an amino acid based dialysate.Kidney Int1995; 47: 1148–57.
29.
FallerB., AparicioM., FaictD.. Clinical evaluation of an optimized 1.1% amino-acid solution for peritoneal dialysis.Nephrol Dial Transplant1995; 10: 1432–7.
30.
MarcusR.G., ChaingE., DimaanoF., UribarriJ.. Serum albumin: associations and significance in peritoneal dialysis.Adv Perit Dial1994; 10: 94–8.
31.
BlakeP.G., SombolosK., AbrahamG.. Lack of correlation between urea kinetic indices and clinical outcomes in CAPD patients [published erratum appears in Kidney Int 1991 Aug; 40(2): 388].Kidney Int1991; 39: 700–6.
32.
LynnR.I., FishbaneS., GinsbergN.S.. The effect of KT/V(urea) on nitrogen appearance and appetite in peritoneal dialysis.Perit Dial Int1995; 15(suppl): S50–2.
33.
DaviesS.J., RussellL., BryanJ., PhillipsL., RussellGI. Comorbidity, urea kinetics, and appetite in continuous ambulatory peritoneal dialysis patients: their interrelationship and prediction of survival.Am J Kidney Dis1995; 26: 353–61.
34.
BistrianB.R.. Role of the systemic inflammatory response syndrome in the development of protein-caloric malnutrition in ESRD.Am J Kidney Dis1998; 32(suppl): S113–7.
35.
PannenB.H.J., RobothamJ.L.. The acute-phase response.New Horizons1995; 3: 183–97.
36.
RoubenoffR., RoubenoffR.A., CannonJ.G.. Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation.J Clin Invest1994; 93: 2379–86.
37.
AguileraA., CodoceoR., SelgasR.. Anorexigen (TNF-alpha, cholecystokinin) and orexigen (neuropeptide Y) plasma levels in peritoneal dialysis (PD) patients: their relationship with nutritional parameters.Nephrol Dial Transplant1998; 13: 1476–83.
38.
MoldawerL.L., CopelandE.M.. Proinflammatory cytokines, nutritional support, and the cachexia syndrome: interactions and therapeutic options.Cancer1997; 79: 1828–39.
39.
SoubaW.W.. Cytokine control of nutrition and metabolism in critical illness.Curr Probl Surg1994; 31: 577–643.
40.
WangT., HeimburgerO., ChengH.H., BergstromJ., LindholmB.. Does a high peritoneal transport rate reflect a state of chronic inflammation?Perit Dial Int1999; 19: 17–22.
41.
NohH., LeeS.W., KangS.W.. Serum C-reactive protein: a predictor of mortality in continuous ambulatory peritoneal dialysis patients.Perit Dial Int1998; 18: 387–94.
42.
RidkerP.M., CushmanM., StampferM.J., TracyR.P., HennekensC.U.. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men [published erratum appears in N Engl J Med 1997 337(5): 356].N Engl J Med1997; 336: 973–9.
43.
RidkerP.M., HaughieP.. Prospective studies of C-reactive protein as a risk factor for cardiovascular disease.J Invest Med1998; 46: 391–5.
44.
TracyR.P., LemaitreR.N., PsatyB.M.. Relationship of C-reactive protein to risk of cardiovascular disease in the eldeily. Results from the Cardiovascular Health Study and the Rural Health Promotion Project.Arterioscler Thromb Vasc Biol1997; 17: 1121–7.
